全文获取类型
收费全文 | 7319篇 |
免费 | 810篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 254篇 |
妇产科学 | 175篇 |
基础医学 | 1143篇 |
口腔科学 | 85篇 |
临床医学 | 969篇 |
内科学 | 1452篇 |
皮肤病学 | 102篇 |
神经病学 | 585篇 |
特种医学 | 352篇 |
外科学 | 896篇 |
综合类 | 150篇 |
一般理论 | 10篇 |
预防医学 | 804篇 |
眼科学 | 167篇 |
药学 | 530篇 |
中国医学 | 4篇 |
肿瘤学 | 427篇 |
出版年
2022年 | 49篇 |
2021年 | 92篇 |
2020年 | 65篇 |
2019年 | 109篇 |
2018年 | 120篇 |
2017年 | 97篇 |
2016年 | 120篇 |
2015年 | 107篇 |
2014年 | 156篇 |
2013年 | 217篇 |
2012年 | 352篇 |
2011年 | 341篇 |
2010年 | 201篇 |
2009年 | 162篇 |
2008年 | 349篇 |
2007年 | 382篇 |
2006年 | 359篇 |
2005年 | 326篇 |
2004年 | 313篇 |
2003年 | 275篇 |
2002年 | 250篇 |
2001年 | 238篇 |
2000年 | 233篇 |
1999年 | 209篇 |
1998年 | 98篇 |
1997年 | 76篇 |
1996年 | 78篇 |
1995年 | 63篇 |
1994年 | 75篇 |
1992年 | 181篇 |
1991年 | 173篇 |
1990年 | 173篇 |
1989年 | 169篇 |
1988年 | 140篇 |
1987年 | 144篇 |
1986年 | 143篇 |
1985年 | 143篇 |
1984年 | 64篇 |
1983年 | 96篇 |
1982年 | 54篇 |
1981年 | 52篇 |
1980年 | 65篇 |
1979年 | 82篇 |
1978年 | 53篇 |
1977年 | 62篇 |
1976年 | 71篇 |
1975年 | 69篇 |
1974年 | 70篇 |
1973年 | 79篇 |
1972年 | 59篇 |
排序方式: 共有8133条查询结果,搜索用时 15 毫秒
81.
Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosis 总被引:16,自引:0,他引:16
Preimplantation genetic diagnosis (PGD) of single gene disorders relies on PCR-based tests performed on single cells (polar bodies or blastomeres). Despite the use of increasingly robust protocols, allele drop-out (ADO; the failure to amplify one of the two alleles in a heterozygous cell) remains a significant problem for diagnosis using single cell PCR. In extreme cases ADO can affect >40% of amplifications and has already caused several PGD misdiagnoses. We suggest that an improved understanding of the origins of ADO will allow development of more reliable PCR assays. In this study we carefully varied reaction conditions in >3000 single cell amplifications, allowing factors influencing ADO rates to be identified. ADO was found to be affected by amplicon size, amount of DNA degradation, freezing and thawing, the PCR programme, and the number of cells simultaneously amplified. Factors found to have little or no affect on ADO were local DNA sequence, denaturing temperature (94 or 96 degrees C) and cell type. Consideration of the causal factors identified during this study should permit the design of PGD protocols that experience little ADO, thus improving the accuracy of PGD for single gene disorders. 相似文献
82.
The primary interest of our laboratory is understanding how the signals that a T cell receives influence its behavior during
an immune response. Recently, we have focused our attention on the examination of T cell responses at an individual cell level.
This article outlines our approach, presents our initial findings, and discusses the implications of these findings relative
to our current models of T cell activation. 相似文献
83.
Pence BW Gaynes BN Whetten K Eron JJ Ryder RW Miller WC 《Journal of acquired immune deficiency syndromes (1999)》2005,40(4):434-444
BACKGROUND: Substance abuse (SA) and mental illness (MI) commonly co-occur with HIV infection in the United States and have important implications for clinical management of HIV/AIDS. Yet SA/MI often go untreated due in part to a lack of practical, validated screening tools. SETTING: HIV clinic in academic medical center. METHODS: The 16-item SA/MI Symptoms Screener (SAMISS) targets SA/MI in HIV-positive patients. Consecutive consenting HIV-positive patients completed the SAMISS and then a reference standard diagnostic tool, SCID, the Structured Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition). RESULTS: Twenty percent of participants (29/148) had an SA diagnosis and 41% (59/143) had an MI diagnosis in the past year on the SCID; 48% (68/143) had 1 or both. Thirty-seven percent (55/148) screened positive for SA and 69% (99/143) screened positive for MI on the SAMISS. The SAMISS had 86% (95% CI: 68%-96%) sensitivity and 75% (66%-82%) specificity for SA and 95% (86%-99%) sensitivity and 49% (38%-60%) specificity for MI. Patients with SA were likely to show up as false positives for MI and vice versa. CONCLUSION: The SAMISS functioned well as a first-line screening tool for SA/MI in this HIV clinic population. It missed few cases and was easily incorporated into a busy clinical setting. Persons screening positive require a more rigorous confirmatory psychiatric evaluation. 相似文献
84.
F. R. Wells 《International journal of experimental pathology》1972,53(4):445-456
The vascular response to the α-toxin of Clostridium perfringens type A, was observed topographically in the cremaster muscle of the rat, in terms of exudation, labelling of damaged vessels by circulating carbon, and in addition histologically for patency of the vascular plexus.It was confirmed that the permeability response is biphasic. The short-lived immediate phase corresponds to that of venular labelling, and the delayed phase reaches its peak rather later than the corresponding phase of capillary labelling. The intensity and extent of these responses are determined by the degree of injury, but their shape and timing, especially in the immediate phase, vary almost as consistently with the duration of exposure to circulating dye or carbon.After the standard dose of toxin, vascular patency is largely unaffected until 24 hours. Apparently irreversible vascular occlusion occurs rather earlier with larger doses. A three-fold reduction of the standard dose proportionately reduces both exudation and capillary labelling but leaves immediate venular labelling unaffected, suggesting that the latter is not dose dependent and therefore non-specific. Prolongation of moderate venular labelling into the middle of the delayed phase may occur at this dosage. Its absence after the standard dose suggests that delayed inhibition of venular reactivity may be occurring.Irregular labelling of venules and small veins persists throughout the delayed phase with doses 2·4 or more times the standard dose. A brief ultramicroscopic survey revealed appearances in both venules and capillaries at 1-2 hours after injury closely comparable to those which have been described for Cl. oedematiens toxin at 6-24 hours.In rats given carbon during the delayed phase, the effective vascular patency 10 minutes later includes half of the labelled capillaries up to 10 μm in diameter. This proportion is little affected by toxin dose, but intensely so when the carbon clearance time is increased, suggesting that such injured microvessels may be a major source of plasma protein exudation. 相似文献
85.
86.
87.
88.
Wells GD Plyley M Thomas S Goodman L Duffin J 《European journal of applied physiology》2005,94(5-6):527-540
The efficiency of the respiratory system presents significant limitations on the bodys ability to perform exercise due to the effects of the increased work of breathing, respiratory muscle fatigue, and dyspnoea. Respiratory muscle training is an intervention that may be able to address these limitations, but the impact of respiratory muscle training on exercise performance remains controversial. Therefore, in this study we evaluated the effects of a 12-week (10 sessions week–1) concurrent inspiratory and expiratory muscle training (CRMT) program in 34 adolescent competitive swimmers. The CRMT program consisted of 6 weeks during which the experimental group (E, n=17) performed CRMT and the sham group (S, n=17) performed sham CRMT, followed by 6 weeks when the E and S groups performed CRMT of differing intensities. CRMT training resulted in a significant improvement in forced inspiratory volume in 1 s (FIV1.0) (P=0.050) and forced expiratory volume in 1 s (FEV1.0) (P=0.045) in the E group, which exceeded the S groups results. Significant improvements in pulmonary function, breathing power, and chemoreflex ventilation threshold were observed in both groups, and there was a trend toward an improvement in swimming critical speed after 12 weeks of training (P=0.08). We concluded that although swim training results in attenuation of the ventilatory response to hypercapnia and in improvements in pulmonary function and sustainable breathing power, supplemental respiratory muscle training has no additional effect except on dynamic pulmonary function variables. 相似文献
89.
Al-Maghrabi J Kamel-Reid S Jewett M Gospodarowicz M Wells W Banerjee D 《Archives of pathology & laboratory medicine》2001,125(3):332-336
CONTEXT: Primary lymphoma of the urinary bladder is rare. Only 84 cases have been reported in the English literature to date, and none of these cases has had molecular confirmation of clonal immunoglobulin gene rearrangement. OBJECTIVES: To review all cases with primary urinary bladder lymphoma in our records, to classify them using the REAL classification, to confirm their immunophenotype and genotype, and to determine their outcome. DESIGN: We identified 4 cases of primary urinary bladder lymphoma in our medical records from a 30-year period. Immunohistochemical detection of immunoglobulin light chains and molecular analysis of immunoglobulin heavy-chain genes using the polymerase chain reaction were performed on paraffin-embedded material. RESULTS: All patients were older than 60 years. The male-female ratio was 1:3. All patients had a history of chronic cystitis. Histologic features of mucosa-associated lymphoid tissue lymphoma with centrocyte-like cells, plasmacytoid B cells, or both were observed in all cases. Monoclonality of B cells was demonstrated by immunohistochemistry, polymerase chain reaction, or both methods in every case. All patients presented with stage IAE disease, were treated with radiotherapy alone, and have been in continuous complete remission for 2 to 13 years. CONCLUSIONS: Primary bladder lymphomas are usually of low-grade mucosa-associated lymphoid tissue type. They are more common in females and are associated with a history of chronic cystitis. Lymphoepithelial lesions are seen only in association with areas of cystitis glandularis. B-cell clonality is readily demonstrable by immunohistochemistry and/or polymerase chain reaction analysis. Local radiotherapy appears to confer long-term control. 相似文献
90.
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism 总被引:30,自引:0,他引:30
Kearon C Gent M Hirsh J Weitz J Kovacs MJ Anderson DR Turpie AG Green D Ginsberg JS Wells P MacKinnon B Julian JA 《The New England journal of medicine》1999,340(12):901-907
BACKGROUND: Patients who have a first episode of venous thromboembolism in the absence of known risk factors for thrombosis (idiopathic thrombosis) are often treated with anticoagulant therapy for three months. Such patients may benefit from longer treatment, however, because they appear to have an increased risk of recurrence after anticoagulant therapy is stopped. METHODS: In this double-blind study, we randomly assigned patients who had completed 3 months of anticoagulant therapy for a first episode of idiopathic venous thromboembolism to continue receiving warfarin, with the dose adjusted to achieve an international normalized ratio of 2.0 to 3.0, or to receive placebo for a further 24 months. Our goal was to determine the effects of extended anticoagulant therapy on rates of recurrent symptomatic venous thromboembolism and bleeding. RESULTS: A prespecified interim analysis of efficacy led to the early termination of the trial after 162 patients had been enrolled and followed for an average of 10 months. Of 83 patients assigned to continue to receive placebo, 17 had a recurrent episode of venous thromboembolism (27.4 percent per patient-year), as compared with 1 of 79 patients assigned to receive warfarin (1.3 percent per patient-year, P<0.001). Warfarin resulted in a 95 percent reduction in the risk of recurrent venous thromboembolism (95 percent confidence interval, 63 to 99 percent). Three patients assigned to the warfarin group had nonfatal major bleeding (two had gastrointestinal bleeding and one genitourinary bleeding), as compared with none of those assigned to the placebo group (3.8 vs. 0 percent per patient-year, P=0.09). CONCLUSIONS: Patients with a first episode of idiopathic venous thromboembolism should be treated with anticoagulant agents for longer than three months. 相似文献